Xboxlab Group

What Xboxlab Group does

XboXLab AB, trading as XboXLab Group, is a Sweden-headquartered specialty distributor of in-vitro diagnostic and life-science products headquartered in Tranås. Founded in 2016, the company has built a three-country Nordic distribution platform through dedicated subsidiaries in Sweden, Norway (established 2019), and Finland (established 2020, supported by the acquisition of Medic24). It distributes products from 30+ international suppliers spanning point-of-care rapid tests (Sofia, AFIAS, iChroma), molecular diagnostics (LOAA Digital PCR), hematology (HemoFlow), gastrodiagnostics (GastroPanel), transplantation diagnostics (NanoTYPE HLA sequencing), and inflammatory markers (suPARnostic), serving clinical laboratories, hospitals, blood banks, and other healthcare facilities across the Nordic region. The company holds ISO 9001 and ISO 14001 certifications and employs dedicated local sales and technical-support representatives in each Nordic country. In June 2026 XboXLab was consolidated, alongside peer Nordic distributors, into Sanviva — a pan-Nordics diagnostics distribution platform formed under the sponsorship of Nordic private-equity firm Axcel — bringing the combined entity to roughly 60 employees across approximately six European countries.

The business model is straightforward specialty distribution: XboXLab purchases diagnostic instruments, reagents, and consumables from international manufacturers and resells them to Nordic end customers, earning a distribution margin while providing pre-sales technical consultation, regulatory-localization support, after-sales service, and instrument-menu validation. Revenue mechanics are therefore gross-margin-spread distribution plus service and support fees, with country-specific sales forces driving coverage of fragmented public and private laboratory customers. Recent strategic activity — including the 2026 ANCHOR Diagnostics partnership, NanoTYPE HLA sequencing launch, and Arlington Scientific partnership — indicates a continuing strategy of broadening the supplier portfolio and deepening category coverage per country rather than building proprietary technology. The Sanviva consolidation signals an intent to realize procurement, logistics, and cross-selling scale across a wider Nordic footprint under PE ownership.

Name

Xboxlab Group

Legal name

XboXLab AB

Website

https://xboxlab.se

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

XboXLab AB is a Sweden-based specialty distributor of in-vitro diagnostic and life-science products, serving Nordic clinical laboratories, hospitals, and blood banks via subsidiaries in Sweden, Norway, and Finland. It distributes diagnostic platforms and reagents from 30+ international manufacturers and was consolidated into the Axcel-sponsored Sanviva platform in 2026.

Ownership category

akta.pro rank

Headquarters

HQ city

Tranås

HQ country

Sweden

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Product Distribution: XboXLab generates revenue through distributing laboratory and diagnostic products from multiple international suppliers to customers in Sweden, Norway, and Finland. The company acts as a distributor, reselling products from carefully selected suppliers to laboratories, hospitals, and healthcare facilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

XboXLab Group is a Nordic distributor of laboratory and diagnostic products representing more than 30 international MedTech suppliers. The company distributes diagnostic products across ten disciplines — flow cytometry/pathology, research, gastroenterology, immunology, clinical chemistry, microbiology, molecular diagnostics, point-of-care testing, transfusion/transplantation, and ophthalmology — to laboratories, hospitals, and healthcare facilities in Sweden, Norway, and Finland through its wholly-owned subsidiaries XboXLab AB, XboXLab AS, and XboXLab Oy.

Product overview

XboXLab Group is a Nordic distributor of laboratory and diagnostic products representing a diverse portfolio of international MedTech suppliers. The company operates across Sweden, Norway, and Finland (with subsidiary companies XboXLab AB, XboXLab AS, and XboXLab Oy), distributing products in ten categories: Flow/Pathology, Research, Gastro, Immunology, Clinical Chemistry, Microbiology, Molecular Diagnostics, Point-of-Care Testing (PNA), Transfusion/Transplantation, and Ophthalmology. As of June 2026, XboXLab Group became part of Sanviva, a European medical device distribution network. Key distributed products include Sofia and AFIAS immunoassay platforms, LOAA digital PCR systems, HemoFlow blood banking equipment, GastroPanel quick tests, NanoTYPE HLA sequencing, suPARnostic prognostic biomarkers, and various multiplex PCR panels for infectious disease and fungal diagnostics. The company maintains ISO 9001 and ISO 14001 certifications and represents over 30 international diagnostic suppliers.

Differentiator

Problem solved

Functional benefit

Products and services

• Sofia System
• AFIAS / iChroma Systems
• LOAA Digital PCR System
• HemoFlow 400 / 400XS
• GastroPanel Quick Test
• NanoTYPE HLA Sequencing
• suPARnostic Products
• M30 Apoptosense ELISA and M65 EpiDeath ELISA
• DNlite Test
• DermaGenius / AsperGenius / PneumoGenius / MucorGenius
• The Eagle (Belkin Vision)
• HemaVision-28Q
• RPR Test Cards (Arlington Scientific)
• MXA/CRP Combo Test

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• ANCHOR DiagnosticscoreChannel Partner/ Reseller/ Distributor · 16 January 2026XboXLab entered a distribution partnership with ANCHOR Diagnostics, offering high-quality, fast, and reliable diagnostic solutions for optimized molecular testing of infectious diseases.
• EqualisminorChannel Partner/ Reseller/ Distributor · 13 October 2022XboXLab participates in Equalis PNA (Patient-Near-Testing) education days in Stockholm, showcasing relevant PNA products.
• ViroGatescoreChannel Partner/ Reseller/ Distributor · 30 August 2021XboXLab signed a distribution agreement with Danish company ViroGates for suPARnostic® products in Sweden, Finland, and Norway. suPARnostic® products measure the concentration of soluble uPAR protein in blood circulation, serving as a marker for immune activation.
• Supplier NetworkcoreOthersXboXLab maintains partnerships with numerous international diagnostic product suppliers including: ImmunDiagnostik, Salimetrics, RSR, Mesa Biotech, Virotech Diagnostics, Helvetica Health Care, Medipan, Sphingotec, Preventis, Applied Science, Qnostics, StressMarq, CTK Biotech, Oxford Immunotec, AnshLabs, Quidel, Pathonostics, Pathofinder, Diasource, BDR, Tridentify, Immucor, Eurolyser, IBL-Japan, Biohit, Immunostep, Oncimmune, Exosomics, Tecomedical, Boditech, ELITech, Macherey-Nagel, YHLO, DiaMex, DNA Diagnostik, ELK Biotechnology, Gencurix, Gold Standard Diagnostics, Panpath, Optolane, BioLab Assays, BPM, VLVbio, ViroGates, Generic Assays, Nal von Minden, Delta Life Science, and others.
• Sanviva (Axcel PE)coreStrategic or Co-development PartnerXboXLab Group became part of Sanviva, a European MedTech distribution network consolidated by Nordic private equity firm Axcel. The consolidation brings together four regional distributors (Apodan Denmark, PartnerMed Norway, AllweCare Medical Netherlands, XboXLab Sweden) into a unified pan-European platform.

Scale indicators3 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• VWR (Avantor): Global laboratory supplies distributor with deep Nordic presence. Competes with XboXLab in distributing reagents, consumables and instruments to clinical and research laboratories, though at much broader scale.
• Henry Schein: Global distributor of healthcare products including medical, dental and animal health, with European operations. Overlaps with XboXLab in specialty medical device distribution but operates a far broader portfolio.
• Cardinal Health: Major US-headquartered medical products distributor with growing European footprint. Indirectly comparable as a large-scale medical device and laboratory products channel partner, though with very different geographic mix.
• Mediq: Large European distributor of medical devices, homecare and self-care products operating across multiple countries. Overlaps with XboXLab in hospital/laboratory device distribution but at significantly larger scale and broader portfolio.

Direct peers

• PartnerMed: Norwegian medical device distributor that, together with XboXLab, was acquired by Axcel in 2026 to form Sanviva. Provides directly comparable specialty distribution into Norwegian healthcare customers.
• Sarstedt: European manufacturer and distributor of laboratory and medical consumables (blood collection, sample handling) with direct Nordic sales presence. Comparable as a channel for laboratory supplies into European clinical labs.
• AllweCare Medical: Dutch medical device distributor and the fourth leg of the Sanviva platform formed by Axcel. Same channel-partner business model as XboXLab but serving the Netherlands/Benelux market.
• AddVision: Swedish life science and diagnostic distributor offering reagents, instruments and consumables to Nordic research and clinical customers. Closely comparable business model and geographic focus to XboXLab.
• Apodan: Danish medical device distributor now consolidated into the Sanviva platform alongside XboXLab. Operates an essentially identical model of distributing imported MedTech products to Nordic hospital and laboratory customers.
• BioNordika: Nordic life science distributor covering Sweden, Denmark, Norway, Finland and the Baltics with laboratory reagents, consumables and diagnostic instruments. Directly comparable to XboXLab as a regional specialty channel partner for international life science suppliers.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xboxlab Group